Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: Transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity

Human Molecular Genetics

Volumn 21, Issue 10, 2012, Pages 2312-2329

  Hodge, Jennelle C ^a,b,c   Kim, Tae Min ^b   Dreyfuss, Jonathan M ^d   Somasundaram, Priya ^a   Christacos, Nicole C ^a,b,f   Rousselle, Marissa ^a   Quade, Bradley J ^a,b   Park, Peter J ^b,d,e   Stewart, Elizabeth A ^a,b,c   Morton, Cynthia C ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d LABORATORY FOR MOLECULAR MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 7Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; HMGA2 GENE; HUMAN; HUMAN TISSUE; MOSAICISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; UTERUS MYOMA;

CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HMGA2 PROTEIN; HUMANS; KARYOTYPING; LEIOMYOMA; MYOMETRIUM; TRANSCRIPTION, GENETIC; UTERINE NEOPLASMS;

EID: 84860432515     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds051     Document Type: Article

References (74)

1. Cramer, S.F. and Patel, A. (1990) The frequency of uterine leiomyomas. Am. J. Clin. Pathol., 94, 435-438.
2. Coronado, G.D., Marshall, L.M. and Schwartz, S.M. (2000) Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet. Gynecol., 95, 764-769.
3. Buttram, V.C. Jr and Reiter, R.C. (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil. Steril., 36, 433-445.
4. Viswanathan, M., Hartmann, K., McKoy, N., Stuart, G., Rankins, N., Thieda, P., Lux, L.J. and Lohr, K.N. (2007) Management of uterine fibroids: an update of the evidence. Evid. Rep. Technol. Assess. (Full Rep), 154, 1-122.
5. Flynn, M., Jamison, M., Datta, S. and Myers, E. (2006) Health care resource use for uterine fibroid tumors in the United States. Am. J. Obstet. Gynecol., 195, 955-964.
6. Hartmann, K.E., Birnbaum, H., Ben-Hamadi, R., Wu, E.Q., Farrell, M.H., Spalding, J. and Stang, P. (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet. Gynecol., 108, 930-937.
7. Lepine, L.A., Hillis, S.D., Marchbanks, P.A., Koonin, L.M., Morrow, B., Kieke, B.A. and Wilcox, L.S. (1997) Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill. Summ., 46, 1-15.
8. Nilbert, M. and Heim, S. (1990) Uterine leiomyoma cytogenetics. Genes Chrom. Cancer, 2, 3-13.
9. Rein, M.S., Friedman, A.J., Barbieri, R.L., Pavelka, K., Fletcher, J.A. and Morton, C.C. (1991) Cytogenetic abnormalities in uterine leiomyomata. Obstet. Gynecol., 77, 923-926.
10. Meloni, A.M., Surti, U., Contento, A.M., Davare, J. and Sandberg, A.A. (1992) Uterine leiomyomas: cytogenetic and histologic profile. Obstet. Gynecol., 80, 209-217.
11. Hennig, Y., Deichert, U., Bonk, U., Thode, B., Bartnitzke, S. and Bullerdiek, J. (1999) Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol. Hum. Reprod., 5, 1150-1154.
12. Brosens, I., Deprest, J., Dal Cin, P. and Van den Berghe, H. (1998) Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil. Steril., 69, 232-235.
13. Rein, M.S., Powell, W.L., Walters, F.C., Weremowicz, S., Cantor, R.M., Barbieri, R.L. and Morton, C.C. (1998) Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol. Human Repro., 4, 83-86.
14. Gross, K.L., Neskey, D.M., Manchanda, N., Weremowicz, S., Kleinman, M.S., Nowak, R.A., Ligon, A.H., Rogalla, P., Drechsler, K., Bullerdiek, J. et al. (2003) HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chrom. Cancer, 38, 68-79.
15. Gattas, G.J., Quade, B.J., Nowak, R.A. and Morton, C.C. (1999) HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chrom. Cancer, 25, 316-322.
16. Wolffe, A.P. (1994) Architectural transcription factors. Science, 264, 1100-1101.
17. Reeves, R. (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene, 277, 63-81.
18. Ashar, H.R., Cherath, L., Przybysz, K.M. and Chada, K. (1996) Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas. Genomics, 31, 207-214.
19. Grosschedl, R., Giese, K. and Pagel, J. (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet., 10, 94-100.
20. Hirning-Folz, U., Wilda, M., Rippe, V., Bullerdiek, J. and Hameister, H. (1998) The expression pattern of the Hmgic gene during development. Genes Chrom. Cancer, 23, 350-357.
21. Zhou, X., Benson, K.F., Ashar, H.R. and Chada, K. (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature, 376, 771-774.
22. Rogalla, P., Drechsler, K., Frey, G., Hennig, Y., Helmke, B., Bonk, U. and Bullerdiek, J. (1996) HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am. J. Pathol., 149, 775-779.
23. Zhou, X., Benson, K.F., Przybysz, K., Liu, J., Hou, Y., Cherath, L. and Chada, K. (1996) Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res., 24, 4071-4077.
24. Nissen, M.S., Langan, T.A. and Reeves, R. (1991) Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem., 266, 19945-19952.
25. Hodge, J.C., T Cuenco, K., Huyck, K.L., Somasundaram, P., Panhuysen, C.I., Stewart, E.A. and Morton, C.C. (2009) Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum. Genet., 125, 257-263.
26. Weedon, M.N., Lettre, G., Freathy, R.M., Lindgren, C.M., Voight, B.F., Perry, J.R., Elliott, K.S., Hackett, R., Guiducci, C., Shields, B. et al. (2007) A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat. Genet., 39, 1245-1250.
27. Ligon, A.H., Moore, S.D., Parisi, M.A., Mealiffe, M.E., Harris, D.J., Ferguson, H.L., Quade, B.J. and Morton, C.C. (2005) Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am. J. Hum. Genet., 76, 340-348.
28. Berthois, Y., Katzenellenbogen, J.A. and Katzenellenbogen, B.S. (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl Acad. Sci. USA, 83, 2496-2500.
29. Hashimoto, K., Azuma, C., Kamiura, S., Kimura, T., Nobunaga, T., Kanai, T., Sawada, M., Noguchi, S. and Saji, F. (1995) Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol. Obstet. Invest., 40, 204-208.
30. Linder, D. and Gartler, S.M. (1965) Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science, 150, 67-69.
31. Mashal, R.D., Fejzo, M.L., Friedman, A.J., Mitchner, N., Nowak, R.A., Rein, M.S., Morton, C.C. and Sklar, J. (1994) Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chrom. Cancer, 11, 1-6.
32. Hodge, J.C., Park, P.J., Dreyfuss, J.M., Assil-Kishawi, I., Somasundaram, P., Semere, L.G., Quade, B.J., Lynch, A.M., Stewart, E.A. and Morton, C.C. (2009) Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis. Genes Chrom. Cancer, 48, 865-885.
33. Storey, J.D. and Tibshirani, R. (2003) Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA, 100, 9440-9445.
34. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
35. Johnson, W.E., Li, C. and Rabinovic, A. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
36. Fusco, A. and Fedele, M. (2007) Roles of HMGA proteins in cancer. Nat. Rev. Cancer, 7, 899-910.
37. Schoenmakers, E.F., Wanschura, S., Mols, R., Bullerdiek, J., Van den Berghe, H. and Van de Ven, W.J. (1995) Recurrent rearrangements in thehigh mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat. Genet., 10, 436-444.
38. Berner, J.M., Meza-Zepeda, L.A., Kools, P.F., Forus, A., Schoenmakers, E.F., Van de Ven, W.J., Fodstad, O. and Myklebost, O. (1997) HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene, 14, 2935-2941.
39. Cha, P.C., Takahashi, A., Hosono, N., Low, S.K., Kamatani, N., Kubo, M. and Nakamura, Y. (2011) A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat. Genet., 43, 447-450.
40. Geurts, J.M., Schoenmakers, E.F., Roijer, E., Astrom, A.K., Stenman, G. and van de Ven, W.J. (1998) Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene, 16, 865-872.
41. Hensen, K., Braem, C., Declercq, J., Van Dyck, F., Dewerchin, M., Fiette, L., Denef, C. and Van de Ven, W.J. (2004) Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility. Dev. Growth Differ., 46, 459-470.
42. Hensen, K., Van Valckenborgh, I.C., Kas, K., Van de Ven, W.J. and Voz, M.L. (2002) The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res., 62, 1510-1517.
43. Voz, M.L., Mathys, J., Hensen, K., Pendeville, H., Van Valckenborgh, I., Van Huffel, C., Chavez, M., Van Damme, B., De Moor, B., Moreau, Y. et al. (2004) Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene, 23, 179-191.
44. Landrette, S.F., Kuo, Y.H., Hensen, K., Barjesteh van Waalwijk van Doorn-Khosrovani, S., Perrat, P.N., Van de Ven, W.J., Delwel, R. and Castilla, L.H. (2005) Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood, 105, 2900-2907.
45. Nohara, A., Ohmichi, M., Koike, K., Jikihara, H., Kimura, A., Masuhara, K., Ikegami, H., Inoue, M., Miyake, A. and Murata, Y. (1997) Prolactin stimulates mitogen-activated protein kinase in human leiomyoma cells. Biochem. Biophys. Res.Commun., 238, 473-477.
46. Nowak, R.A., Mora, S., Diehl, T., Rhoades, A.R. and Stewart, E.A. (1999) Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol. Obstet. Invest., 48, 127-132.
47. Arslan, A.A., Gold, L.I., Mittal, K., Suen, T.C., Belitskaya-Levy, I., Tang, M.S. and Toniolo, P. (2005) Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum. Reprod., 20, 852-863.
48. Lefebvre, L., Viville, S., Barton, S.C., Ishino, F., Keverne, E.B. and Surani, M.A. (1998) Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat. Genet., 20, 163-169.
49. Skubitz, K.M. and Skubitz, A.P. (2003) Differential gene expression in uterine leiomyoma. J. Lab. Clin. Med., 141, 297-308.
50. Rho, S.B., Byun, H.J., Park, S.Y. and Chun, T. (2008) Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis. Cancer Lett., 271, 306-313.
51. Satterwhite, E., Sonoki, T., Willis, T.G., Harder, L., Nowak, R., Arriola, E.L., Liu, H., Price, H.P., Gesk, S., Steinemann, D. et al. (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood, 98, 3413-3420.
52. Grossel, M.J., Baker, G.L. and Hinds, P.W. (1999) cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain. J. Biol. Chem., 274, 29960-29967.
53. Resnitzky, D., Gossen, M., Bujard, H. and Reed, S.I. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.
54. Timmermann, S., Hinds, P.W. and Munger, K. (1997) Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ., 8, 361-370.
55. Donnellan, R. and Chetty, R. (1998) Cyclin D1 and human neoplasia. Mol. Pathol., 51, 1-7.
56. Easton, J., Wei, T., Lahti, J.M. and Kidd, V.J. (1998) Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Cancer Res., 58, 2624-2632.
57. Costello, J.F., Plass, C., Arap, W., Chapman, V.M., Held, W.A., Berger, M.S., Su Huang, H.J. and Cavenee, W.K. (1997) Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res., 57, 1250-1254.
58. Lanahan, A., Williams, J.B., Sanders, L.K. and Nathans, D. (1992) Growth factor-induced delayed early response genes. Mol. Cell. Biol., 12, 3919-3929.
59. Tavtigian, S.V., Zabludoff, S.D. and Wold, B.J. (1994) Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol. Biol. Cell, 5, 375-388.
60. Li, D., Lin, H.H., McMahon, M., Ma, H. and Ann, D.K. (1997) Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J. Biol. Chem., 272, 25062-25070.
61. Ayoubi, T.A., Jansen, E., Meulemans, S.M. and Van de Ven, W.J. (1999) Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene, 18, 5076-5087.
62. Brants, J.R., Ayoubi, T.A., Chada, K., Marchal, K., Van de Ven, W.J. and Petit, M.M. (2004) Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2. FEBS Lett., 569, 277-283.
63. Cleynen, I., Brants, J.R., Peeters, K., Deckers, R., Debiec-Rychter, M., Sciot, R., Van de Ven, W.J. and Petit, M.M. (2007) HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res., 5, 363-372.
64. Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A.H., Wewer, U.M. and Nielsen, F.C. (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol., 19, 1262-1270.
65. Stewart, E.A. and Nowak, R.A. (1998) New concepts in the treatment of uterine leiomyomas. Obstet. Gynecol., 92, 624-627.
66. Semenza, G.L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer, 3, 721-732.
67. Forristal, C.E., Wright, K.L., Hanley, N.A., Oreffo, R.O. and Houghton, F.D. (2010) Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction, 139, 85-97.
68. Cheung, V.G., Nowak, N., Jang, W., Kirsch, I.R., Zhao, S., Chen, X.N., Furey, T.S., Kim, U.J., Kuo, W.L., Olivier, M. et al. (2001) Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature, 409, 953-958.
69. Karolchik, D., Baertsch, R., Diekhans, M., Furey, T.S., Hinrichs, A., Lu, Y.T., Roskin, K.M., Schwartz, M., Sugnet, C.W., Thomas, D.J. et al. (2003) The UCSC Genome Browser Database. Nucleic Acids Res., 31, 51-54.
70. Moore, S.D., Herrick, S.R., Ince, T.A., Kleinman, M.S., Cin, P.D., Morton, C.C. and Quade, B.J. (2004) Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res., 64, 5570-5577.
71. Bismar, T.A., Demichelis, F., Riva, A., Kim, R., Varambally, S., He, L., Kutok, J., Aster, J.C., Tang, J., Kuefer, R. et al. (2006) Defining aggressive prostate cancer using a 12-gene model. Neoplasia, 8, 59-68.
72. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J. et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol., 5, R80.
73. Smyth, G.K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article3.
74. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A. et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.